Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
5
×
boston top stories
life sciences
national blog main
national top stories
cancer
new york blog main
san francisco blog main
startups
cancer drugs
clinical trials
deals
gilead sciences
hepatitis b
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san francisco top stories
seattle blog main
seattle top stories
takeda pharmaceutical
abbvie
adeno-associated virus
agios pharmaceuticals
allergan aesthetics
alnylam pharmaceuticals
alzheimer's disease
amgen
astrazeneca
athira pharma
attralus
beijing
biobucks
biontech
boehringer ingelheim
boston
boulder/denver blog main
boulder/denver top stories
brii bio
What
pipeline
5
×
drug
medicines
adding
build
company’s
gilead
million
sciences
therapeutics
acquisitions
adds
ago
aiming
alliance
areas
balance
bets
biggest
bio
biosciences
bio’s
boost
brii
buy
cancer
ceo
course
daniel
debut
decibel
development
discover
disease
drugs
dyne’s
earlier
emerged
expensive
experimental
Language
unset
Current search:
pipeline
×
" boston blog main "
×
@xconomy.com
3 years ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
@xconomy.com
4 years ago
Decibel Therapeutics Strikes a Balance, Adding Regenerative Med Focus
@xconomy.com
4 years ago
Schrödinger Sets Course for IPO to Support Growing Internal Pipeline
@xconomy.com
5 years ago
Brii Bio’s Alliance with VBI Vaccines Adds Hepatitis B Drug to Pipeline
@xconomy.com
5 years ago
To Boost Cancer Pipeline, Gilead Bets at Least $50M on Startup Tango